Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses.
Emma Rose McGloneIain M CareyVladica VeličkovićPrem ChanaKamal MahawarRachel L BatterhamJames HopkinsPeter WaltonRobin KinsmanJames ByrneShaw SomersDavid KerriganVinod MenonCynthia-Michelle BorgAhmed R AhmedBruno SgromoChandra CheruvuGul BanoCatherine LeonardHoward ThomCarel W le RouxMarcus ReddyRichard WelbournPeter SmallOmar A KhanPublished in: PLoS medicine (2020)
In this study, we observed that in patients with obesity and T2DM-Ins, bariatric surgery was associated with high rates of postoperative cessation of insulin therapy, which is, in turn, a major driver of overall reductions in direct healthcare cost. Our findings suggest that a strategy utilising bariatric surgery for patients with obesity and T2DM-Ins is cost saving to the national healthcare provider (National Health Service (NHS)) over a 5-year time horizon.
Keyphrases
- bariatric surgery
- weight loss
- glycemic control
- healthcare
- type diabetes
- obese patients
- quality improvement
- insulin resistance
- weight gain
- patient safety
- metabolic syndrome
- primary care
- patients undergoing
- high fat diet induced
- sensitive detection
- fluorescent probe
- quantum dots
- physical activity
- skeletal muscle
- health information
- bone marrow